首页|深圳市盐酸利托君不良反应报告分析和风险信号挖掘

深圳市盐酸利托君不良反应报告分析和风险信号挖掘

扫码查看
目的 为临床安全使用盐酸利托君提供参考。方法 通过广东省药物警戒与风险管控系统收集 2017 年 1 月 1 日至 2021 年12 月 31 日上报至国家药品不良反应监测中心的深圳市药品不良反应(ADR)监测数据。共得到 775 条数据记录,涉及患者 698 例,共发生ADR 1 389 例次,其中盐酸利托君相关的为 51 例、147 例次。根据 2015 年版《世界卫生组织不良反应术语集》统计ADR累及系统/器官。运用报告比值比法、比例报告比法和综合标准法对盐酸利托君ADR信号进行挖掘。结果 147 例次盐酸利托君相关ADR共涉及 12 种系统/器官,54 种临床表现,分别以全身疾病(36 例次,24。49%)和胸闷(20 例次,13。61%)最常见。以第 32 孕周发生ADR例次及患者数最多。胸闷、心悸、心慌、心动过速、气促、心律失常、局部颤抖、低钾血症、局部麻木 9 类ADR信号检测结果有统计学意义(P<0。05),其中胸闷、气促和局部颤抖为新的ADR。结论 盐酸利托君的ADR多与其对肾素-血管紧张素-醛固酮系统的激活叠加妊娠期人体生理变化有关,临床使用时需严格控制剂量与时机(孕周),加强监测,关注高龄(≥35岁)孕妇用药情况,减少严重ADR的发生。
Analysis of Adverse Reaction Reports and Risk Signal Mining of Ritodrine Hydrochloride in Shenzhen
Objective To provide a reference for the clinical safe use of ritodrine hydrochloride.Methods The adverse drug reaction(ADR)monitoring data in Shenzhen reported to the National Center for Adverse Drug Reaction Monitoring from January 1,2017 to December 31,2021 were collected from the Guangdong Province Pharmacovigilance and Risk Control System.A total of 775 pieces of data were obtained,involving 698 patients and 1 389 case times of ADRs,of which 51 cases(147 case times)of ADR were related to ritodrine hydrochloride.Based on the World Health Organization Adverse Reaction Terminology(2015 Edition),the systems/organs involved in ADRs were recorded.The ADR signals of ritodrine hydrochloride were mined by the reporting odds ratio(ROR),proportional reporting ratio(PRR)and Medicines and Healthcare Products Regulatory Agency(MHRA)methods.Results A total of 147 case times of ritodrine hydrochloride-related ADRs involved 12 systems/organs and 54 clinical manifestations,with the systemic diseases(36 case times,24.49%)and chest tightness(20 case times,13.61%)being the most common.The case times and patients with ADRs occurring at the 32nd week of pregnancy was the most.The detection of nine ADR signals(chest tightness,cardiopalmus,palpitation,tachycardia,short breath,arrhythmia,local tremble,hypokalemia,local numbness)were statistically significant(P<0.05),among which,chest tightness,short breath and local tremble were the new ADRs.Conclusion The ADRs of ritodrine hydrochloride are mostly related to the activation of the renin-angiotensin-aldosterone system and the physiological changes of the human body during pregnancy.When using this drug in the clinic,we need to strictly control the dosage and timing(gestational week),strengthen monitoring,pay attention to the medication of women with advanced maternal age(≥35 years)to decrease the occurrence of severe ADRs.

Shenzhenritodrine hydrochlorideadverse drug reactionsignal miningpregnancy periodthreatened abortion

肖霄、唐碧雨、吴建茹、魏芬芳、李丽敏、吴文宇

展开 >

广东省深圳市药物警戒和风险管理研究院,广东 深圳 518024

深圳市 盐酸利托君 药品不良反应 信号挖掘 妊娠期 先兆流产

广东省自然科学基金广东省药品监督管理局科技创新项目广东省药品监督管理局科技创新项目广东省药品监督管理局科技创新项目广东省药品监督管理局科技创新项目

2023A15150114952021ZDB012021JDB012021TDB062022TDB16

2024

中国药业
重庆市食品药品监督管理局

中国药业

CSTPCD
影响因子:1.369
ISSN:1006-4931
年,卷(期):2024.33(8)
  • 15